Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(9%)
Results Posted
75%(6 trials)

Phase Distribution

Ph phase_2
1
9%
Ph phase_3
2
18%
Ph not_applicable
2
18%
Ph phase_4
5
45%

Phase Distribution

0

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
5(50.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(8)
Terminated(1)
Other(1)

Detailed Status

Completed8
Recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (10.0%)
Phase 32 (20.0%)
Phase 45 (50.0%)
N/A2 (20.0%)

Trials by Status

completed873%
recruiting19%
unknown19%
withdrawn19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11